Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages

References

• Hata K, Kozawa M, and Baba K: New stilbene glucoside from Chinese crude drug He Shou Wu. Roots of Polygonum multiflorum. Yakugaku Zasshi 95, 211–213, 1975 (in Japanese).
   PubMed Web of Science ®Google Scholar
• Hata K, Baba K, and Kozawa M: Chemical studies on the heartwood of Cassia garretiana Craib II. Nonanthroquinoic constituents. Chem Pharm Bull 27, 984–989, 1979.
   Google Scholar
• Kubo M, Kimura Y, Shin H, Haneda T, Tani T, and Namba K: Studies on the antifungal substance of crude drug (II). On the roots of Polygonum cuspidatum Sieb. et Zucc. (Polygonaceae). Shouyakugaku Zasshi 35, 58–64, 1981 (in Japanese).
   Google Scholar
• Kimura Y, Kozawa M, Baba K, and Hata K: New constituents of roots of Polygonum cuspidatum. Planta Med 48, 164–169, 1983.
   PubMed Web of Science ®Google Scholar
• Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, and Arichi S: Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem Pharm Bull 30, 1766–1770, 1982.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Ohminami H, Okuda H, Baba K, Kozawa M, and Arichi S: Effects of stilbene components of roots of Polygonum species on liver injury in peroxidized oil-fed rats. Planta Med 49, 51–54, 1983.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Okuda H, Arichi S: Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 834, 275–278, 1985.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Okuda H, and Arichi S: Effects of stilbene derivatives on arachidonate metabolism in leukocytes. Biochim Biophys Acta 837, 209–212, 1985.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Okuda H, and Kubo M: Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. J Ethnopharmacol 45, 131–139, 1995.
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al.: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218–220, 1997.
   PubMed Web of Science ®Google Scholar
• Ciolino HP, Daschner PJ, and Yeh GC: Resveratrol inhibits transcription of CYP1A in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58, 5707–5712, 1998.
   PubMed Web of Science ®Google Scholar
• Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, et al.: Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochim Biophys Res Commun 250, 53–58, 1998.
   PubMed Web of Science ®Google Scholar
• Fontecave M, Lepoivre M, Elleingand E, Gerez C, and Guittelet O: Resveratrol, a remarkable inhibitor or ribonucleotide reductase. FEBS Lett 421, 277–279, 1998.
   PubMed Web of Science ®Google Scholar
• Subbaranmaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, et al.: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cell. J Biol Chem 273, 21875–21882, 1998.
   PubMed Web of Science ®Google Scholar
• Sun N, Woo SH, Cassady JM, and Snapka RM: DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61, 362–366, 1998.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Baba K, and Okuda H: Inhibitory effects of active substances isolated from Cassia garrettiana heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (Part 1). Anticancer Res 20, 2899–2906, 2000.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Baba K, and Okuda H: Inhibitory effect of active substances isolated from heartwood on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice (Part 2). Anticancer Res 20, 2923–2930, 2000.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Okuda H: Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumor growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol 52, 1287–1295, 2000.
   PubMed Web of Science ®Google Scholar
• Kimura Y: Pharmacological studies on resveratrol. Methods Find Exp Clin Pharmacol 25, 297–310, 2003.
   PubMedGoogle Scholar
• Kimura Y, Sumiyoshi M, and Baba K: Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci 99, 2083–2096, 2008.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Sumiyoshi M: Antitumor actions of anthraquinone- and stilbene-related natural products through anti-angiogenic action. Current Topics in Phytochem 10, 75–96, 2011.
   Google Scholar
• Kitadani Y: Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol 2010, 468725, 2010.
   PubMedGoogle Scholar
• Bruyère F, and Noël A: Lymphangiogenesis: in vitro and in vivo models. FASEB J 24, 8–21, 2010.
   PubMed Web of Science ®Google Scholar
• Ellenberg D, Azae DT, Hallak JA, Tobaigy F, Han KY, et al.: Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retinal Eye Res 29, 208–248, 2010.
   PubMed Web of Science ®Google Scholar
• Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, et al.: Infiltration of COX-2-expressing macrophage is a prerequisite for IL-1β-induced neovascularization and tumor growth. J Clin Invest 115, 2979–2991, 2005.
   PubMed Web of Science ®Google Scholar
• Allavena P, and Mantovani A: Immunology in the clinic review series; focus on cancer: tumor-associated macrophage: undisputed stars of the inflammatory tumor microenvironment. Clin Exp Immunol 167, 195–205, 2012.
   PubMed Web of Science ®Google Scholar
• Schmieder A, Michel J, Schönjaar K, Goerdt S, and Schledzewski K: Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol 22, 289–297, 2012.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Okuda H: Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131, 1844–1849, 2001.
   PubMed Web of Science ®Google Scholar
• Tjiu JW, Chen JS, Shun CT, Lin SJ, Liao TH, et al.: Tumor-associated macrophage-induced invasion and angiogenesis of human basal carcinoma cells by cyclooxygenase-2 induction. J Invest Dermatol 129, 1016–1025, 2009.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Sumiyoshi M: Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis. Phytomedicine 20, 328–336, 2013.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Sumiyoshi M: Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells. Eur J Pharmacol 746, 115–125, 2015.
   PubMed Web of Science ®Google Scholar
• Lewis CE, and Pollard JW: Distinct role of macrophages in different tumor microenvironments. Cancer Res 66, 605–612, 2006.
   PubMed Web of Science ®Google Scholar
• Joyce JA, and Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 9, 239–252, 2009.
   PubMed Web of Science ®Google Scholar
• Sica A, Schioppa T, Mantovani A, and Allavena P: Tumor-associated macrophages are a distinct M2 polarized population promoting tumor progression: potential targets of anti-cancer therapy. Eur J Cancer 42, 717–727, 2006.
   PubMed Web of Science ®Google Scholar
• Sica A, Larghi P, Manicino A, Rubino L, Porta C, et al.: Macrophage polarization in tumor progression. Semin Cancer Biol 18, 349–355, 2008.
   PubMed Web of Science ®Google Scholar
• Gordon S: Alternative activation of macrophages. Nat Rev Immunol 3, 23–35, 2003.
   PubMed Web of Science ®Google Scholar
• Mosser DM: The many faces of macrophage activation. J Leuko Biol 73, 209–212, 2003.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Sica A, Sozzani S, Allavens P, Vecchi A, and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25, 677–686, 2004.
   PubMed Web of Science ®Google Scholar
• Shi VY, Bao L, and Chan LS: Inflammation-driven dermal lymphangiogenesis in atopic dermatitis is associated with CD11b+ macrophage recruitment and VEGF-C up-regulation in the IL-4-transgenic mouse model. Microcirculation 19, 567–579, 2012.
   PubMed Web of Science ®Google Scholar
• Poosti F, Yazdani S, Dolman MEM, Kok R, Chen C, et al.: Targeted inhibition of renal Rho kinase reduces macrophage infiltration and lymphangiogenesis in acute renal allograft rejection. Eur J Pharmacol 694, 111–119, 2012.
   PubMed Web of Science ®Google Scholar
• Watari K, Shibata T, Kawahara A, Sata K, Mabeshima H, et al.: Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages. PLoS One 9, e99568, 2014.
   PubMed Web of Science ®Google Scholar
• Lee KM, Danuser R, Stein JV, Graham D, Nibbs RJB, and Graham GJ: The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density. EMBO J 33, 2564–2580, 2014.
   PubMed Web of Science ®Google Scholar
• Maeng Y-S, Aguilar B, Choi S-I, and Kim EK: Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis. Oncogene doi. 10.1038/onc.2015.73. (Epub ahead of print), 2015.
   PubMed Web of Science ®Google Scholar
• Lee AS, Lee JE, Jung YJ, Kim DH, Kang KP, et al.: Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int 83, 50–62, 2012.
   PubMed Web of Science ®Google Scholar
• Pauda D, and Massagué J: Role of TGFβ in metastasis. Cell Res 19, 89–102, 2009.
   PubMed Web of Science ®Google Scholar
• Tian M, Neil JR, and Schiemann WP: Transforming factor-b and the hallmarks of cancer. Cell Signal 23, 951–962, 2011.
   PubMed Web of Science ®Google Scholar
• Jing N, and Tweardy DJ: Targeting Stat 3 in cancer therapy. Anticancer Drugs 16, 601–607, 2005.
   PubMed Web of Science ®Google Scholar
• Sica A, and Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117, 1155–1166, 2007.
   PubMed Web of Science ®Google Scholar
• Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, et al.: Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 250, 53–58, 1998.
   PubMed Web of Science ®Google Scholar
• Sun NJ, Woo SH, Casssidy JM, and Snapka RM: DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J Nat Prod 61, 362–366, 1998.
   PubMed Web of Science ®Google Scholar
• Clément M-V, Hirpara JL, Chawdhury S-H, and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996–1002, 1998.
   PubMed Web of Science ®Google Scholar
• Savio M, Coppa T, Bianchi L, Vannini V, Maga G, et al.: The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol. Int J Biochem Cell Biol 41, 2493–2502, 2009.
   PubMed Web of Science ®Google Scholar
• Maccario C, Savio M, Ferraro D, Bianchi L, Pizzala R, et al.: The resveratrol analog 4,4′-dihydroxy-trans-stilbene suppresses transformation in normal mouse fibroblasts and inhibits proliferation and invasion of human breast cancer cells. Carcinogenesis 33, 2172–2180, 2012.
   PubMed Web of Science ®Google Scholar
• Kimura Y, and Baba K: Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: Isolation of an active substance, xanthoangelol. Int J Cancer 106, 429–437, 2003.
   PubMed Web of Science ®Google Scholar